ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,510 | +74251.4% | 1,500 | -25.0% | 0.00% | 0.0% |
Q4 2022 | $37 | -99.9% | 2,000 | -1.3% | 0.00% | 0.0% |
Q3 2022 | $38,000 | +280.0% | 2,027 | +284.6% | 0.00% | – |
Q2 2022 | $10,000 | 0.0% | 527 | 0.0% | 0.00% | – |
Q1 2022 | $10,000 | +150.0% | 527 | +246.7% | 0.00% | – |
Q2 2021 | $4,000 | -50.0% | 152 | -49.3% | 0.00% | – |
Q1 2021 | $8,000 | -27.3% | 300 | +50.0% | 0.00% | – |
Q4 2020 | $11,000 | – | 200 | – | 0.00% | – |
Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 22 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $19,000 | +111.1% | 1,186 | +172.0% | 0.00% | – |
Q3 2018 | $9,000 | +80.0% | 436 | +37.1% | 0.00% | – |
Q2 2018 | $5,000 | -80.0% | 318 | -62.0% | 0.00% | -100.0% |
Q1 2018 | $25,000 | 0.0% | 836 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $25,000 | -73.7% | 836 | -66.8% | 0.00% | -75.0% |
Q3 2017 | $95,000 | +66.7% | 2,518 | +23.3% | 0.00% | +100.0% |
Q2 2017 | $57,000 | -45.2% | 2,043 | -32.3% | 0.00% | -60.0% |
Q1 2017 | $104,000 | -40.9% | 3,018 | -50.6% | 0.01% | -37.5% |
Q4 2016 | $176,000 | -37.1% | 6,109 | -30.6% | 0.01% | -46.7% |
Q3 2016 | $280,000 | +34.0% | 8,797 | +36.5% | 0.02% | +25.0% |
Q2 2016 | $209,000 | +38.4% | 6,447 | +51.7% | 0.01% | +20.0% |
Q4 2015 | $151,000 | – | 4,249 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |